Brexit: UK To Change Drug Import And Export Rules From 2021
Guidance Explains When Written Confirmations Will Be Needed For APIs
Executive Summary
New guidance documents issued by the UK regarding medicines regulation after the end of the Brexit transition period cover the import of medicinal products from countries on an approved list, trade in APIs between the UK and third countries, and the acceptance of batch testing under existing mutual recognition agreements.